Recombinant vaccines for COVID-19
SARS-CoV-2, the causative agent of COVID-19, has imposed a major public health threat. Several potential candidate vaccines being rapidly developed are in clinical evaluation. Safety is a major aspect to be considered before deploying such vaccines to the public.
